drugset / Trial / NCT07374978
Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of investigators was to study the effect and safety of Thrombolysis in Intermediate high risk pulmonary embolism patients with low bleeding risk as regards Mortality and bleeding events.
Timeline
- Start
- 2023-07-01
- Primary completion
- 2025-05-01
- Completion
- 2025-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HEPARIN CALCIUM | Other / unclassified | — | Intravenous |
| Comparator | Streptokinase | Protein / enzyme biologic | — | — |
| Comparator | recombinant tissue plasminogen activator | Protein / enzyme biologic | — | — |